logo
Select company
Select metric
$ -346.9MEarnings Before Interest Taxes & Depreciation Amortization (EBITDA)
VS
Market
2
Sector
4
Industry
9
History
-
$ 7.9Close
$ 3.84 - $ 22.77 52-Week Range
Ticker Information

Ticker

MYGN

Company Name

MYRIAD GENETICS INC

Sector

Healthcare

Industry

Diagnostics & Research

Exchange

NASDAQ

MYRIAD GENETICS INC - Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

MYGN - EBITDA Historical data
DateDepreciation, Amortization & AccretionEarning Before Interest & Taxes (EBIT)Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)
6/30/2025$ 69.6M$ -416.5M$ -346.9M
3/31/2025$ 69.9M$ -123.8M$ -53.9M
12/31/2024$ 70.7M$ -120.7M$ -50M
9/30/2024$ 70.9M$ -113.6M$ -42.7M
6/30/2024$ 69.9M$ -153.4M$ -83.5M
3/31/2024$ 68.9M$ -232.6M$ -163.7M
12/31/2023$ 73.2M$ -259.3M$ -186.1M
9/30/2023$ 72.2M$ -279.1M$ -206.9M
6/30/2023$ 71.3M$ -262.3M$ -191M
3/31/2023$ 70.6M$ -164M$ -93.4M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • MYRIAD GENETICS INC's latest trailing twelve months (TTM) EBITDA stands at $ -159M.
  • Over the past 5 years, MYRIAD GENETICS INC's average EBITDA has been $ -97.98M.
  • The median EBITDA for MYRIAD GENETICS INC during this period was $ -78.25M
  • MYRIAD GENETICS INC reached its highest EBITDA over the past 5 years at $ 40.4M.
  • The lowest EBITDA recorded by MYRIAD GENETICS INC in the same timeframe $ -346.9M

MYRIAD GENETICS INC's EBITDA vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

EBITDA Benchmarks
CompanyEBITDA
NEO : NEOGENOMICS INC $ -20.98MOFIX : ORTHOFIX MEDICAL INC $ -11.65MFLGT : FULGENT GENETICS INC $ -32.9MINNV : INNOVAGE HOLDING CORP $ -4.88MCSTL : CASTLE BIOSCIENCES INC $ 32.57MEBS : EMERGENT BIOSOLUTIONS INC $ 344.5MAVNS : AVANOS MEDICAL INC $ -426.6MCDNA : CAREDX INC $ 60.36MLAB : STANDARD BIOTOOLS INC $ -95.89MPSNL : PERSONALIS INC $ -79.29M

Similar metrics to EBITDA:

Definition of Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

[Calculation] EBITDA is a non-GAAP accounting metric that lets investors asses profitability net of expenses dependent on financing decision, tax strategy and depreciation schedules. It is calculated by adding depreciation and amortisation expenses [DepAmor] back to [EBIT].
EBIT + DepAmor
(=) EBITDA EBITDA for MYRIAD GENETICS INC is calculated as follows: EBIT [ $ -233.8M ] + DepAmor [ $ 74.8M ]
(=) EBITDA [ $ -159M ]

MYGN - Earnings Before Interest Taxes & Depreciation Amortization (EBITDA), Last 5 years

$ -346.9M

Minimum

Jun 30, 2025

$ 40.4M

Maximum

Mar 31, 2022

$ -97.98M

Average

$ -78.25M

Median

EBITDA Benchmark Analysis

 The chart above depicts the distribution of EBITDA for companies in the Total Stock Market. The average EBITDA of the companies is $ 58.76M with a standard deviation of $ 166.93M.
The following table provides additional summary stats:
EBITDA in the Market:
filtered constituents3.25K
min$ -493.3M
max$ 590.6M
average$ 58.76M
median$ 8.83M
std$ 166.93M